These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy. Boller F; Orgogozo JM Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536 [No Abstract] [Full Text] [Related]
3. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
4. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective. Pendlebury WW; Solomon PR BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290 [No Abstract] [Full Text] [Related]
5. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
6. Tacrine in Alzheimer's disease. Lachs M N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606 [No Abstract] [Full Text] [Related]
7. Tacrine for Alzheimer's disease. Kelly BT Am Fam Physician; 1995 Sep; 52(3):779. PubMed ID: 7653420 [No Abstract] [Full Text] [Related]
9. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low. Roberts C; Mäkelä P; Ford J; Truman C BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289 [No Abstract] [Full Text] [Related]
10. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response. Levy R BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288 [No Abstract] [Full Text] [Related]
11. [Should Alzheimer disease be treated with tacrine? Review of the literature]. Arsland D; Laake K Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167 [TBL] [Abstract][Full Text] [Related]
12. Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified. Wilcock GK BMJ; 1994 Jun; 308(6942):1507. PubMed ID: 8019291 [No Abstract] [Full Text] [Related]
13. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
14. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
15. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related]
16. Tacrine for Alzheimer's disease. Which patient, what dose? Winker MA JAMA; 1994 Apr; 271(13):1023-4. PubMed ID: 8139061 [No Abstract] [Full Text] [Related]
18. Tacrine for Alzheimer's. Handly M Am Pharm; 1991 Dec; NS31(12):8. PubMed ID: 1763782 [No Abstract] [Full Text] [Related]
19. Tacrine in Alzheimer's disease: pharmacokinetic and clinical comparison of oral and rectal administration. Ahlin A; Hassan M; Junthé T; Nybäck H Int Clin Psychopharmacol; 1994; 9(4):263-70. PubMed ID: 7868848 [TBL] [Abstract][Full Text] [Related]
20. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related] [Next] [New Search]